Home » Newsletters » The Carlat Geriatric Psychiatry Report

The Carlat Geriatric Psychiatry Report

Health Equity (October/November/December) | 2024

View Archived Issues

Learning Objective, Health Equity, October/November/December 2024

October 1, 2024

After reading these articles, you should be able to…

News of Note: Donanemab Gains FDA Approval for Early Alzheimer’s Treatment

October 1, 2024

Stephanie Collier, MD and Talia Puzantian, PharmD, BCPP

The FDA recently approved donanemab for early Alzheimer’s, offering new hope by slowing cognitive decline.

How to Talk to Patients About Ageism and Racism

October 1, 2024

Carmen G. Black, MD, MHS

Dr. Black delves into the intersection of ageism and racism in healthcare, highlighting how both impact patient trust and clinical decisions. She offers strategies for clinicians to acknowledge patient concerns, validate experiences of injustice, and build trust through empathetic care.

Disparities in Dementia Diagnosis

October 1, 2024

Nicolás Pérez Palmer, MD

Dr. Pérez Palmer explores health disparities in geriatric psychiatry, focusing on how social determinants affect dementia diagnosis and treatment among underrepresented populations, while addressing strategies to improve equitable care for older adults.

Considerations in Prescribing Lithium in Older Adults

October 1, 2024

Shireen Wissa, PharmD and Talia Puzantian, PharmD, BCPP

Smart dosing and vigilant monitoring can turn the often-feared lithium into a safe, effective solution for older adults.

Reevaluating Diagnosis Criteria for Minoritized Populations

October 1, 2024

Carmen G. Black, MD, MHS

Dr. Black discusses reevaluating diagnostic criteria for minoritized populations, emphasizing how structural racism in medicine contributes to misdiagnoses and disparities in mental health care. She explores approaches for clinicians to provide more equitable treatment by considering cultural context and addressing unconscious biases in psychiatric assessments.

Moderate Alcohol Use and Cognitive Decline

October 1, 2024

Kathryn Martin, MD, MPH

For years, moderate drinking was seen as harmless or even beneficial. This study challenges that, revealing how even modest alcohol consumption can raise brain iron levels and impair cognitive function.

High-Dose Aspirin and Age Are the Only Convincing Depression Risk Factors in Late Life

October 1, 2024

Kathryn Kieran, MSN, PMHNP-BC

This umbrella review looked at modifiable risk factors for late life depression—and only two stood out.

CME Post-Test, Health Equity, CGPR, October/November/December 2024

October 1, 2024

By successfully completing the test you will be awarded a certificate for 2 CME credit.

Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book
The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
READ MORE

General Psychiatry
KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything
Read More

General Psychiatry
A Scam for Every Woman, Child, and Man: Part 2
1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...
Listen now